Guidance

MMRV: patient group direction (PGD) template

PGD template to support the national MMRV vaccination programme.

From:
UK Health Security Agency
Published
27 November 2025

Applies to England

Documents

MMRV: patient group direction (PGD) template

MS Word Document, 267 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of measles, mumps, rubella and varicella (MMRV) vaccine, to individuals from one year of age for routine immunisation or from 9 months of age if early protection is required against varicella, in accordance with the national immunisation programme and the UK Health Security Agency (UKHSA) guidelines on varicella outbreak management.

MMRV vaccine PGD version 1.0 is valid from 1 January 2026 to 30 November 2028.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy and procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Updates to this page

Published 27 November 2025

Sign up for emails or print this page